Try our Advanced Search for more refined results

Accutane Ruling Could Have Ripple Effect Beyond NJ

By Sindhu Sundar (April 6, 2015, 10:03 PM EDT) -- A New Jersey judge's breakthrough finding that Hoffmann-La Roche Ltd.'s post-2002 label sufficiently warned that its acne drug Accutane was linked to inflammatory bowel disease gives the drugmaker a definitive edge in the consolidated litigation, as experts say his detailed analysis supporting the newer warnings could bode ill for many plaintiffs across the country....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!